JOHNSON & JOHNSON
- SEC CIK
- 0000200406
RAPP holding history
Rapport Therapeutics, Inc.
Every 13F filing in which JOHNSON & JOHNSON reported holding RAPP, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
RAPP overviewAll 13F holders of RAPPFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 1,784,517 | $74.36M | 9.31% | 00.0% | Unchanged |
| Q1 2026 | 1,784,517 | $55.84M | 8.56% | 00.0% | Unchanged |
| Q4 2025 | 1,784,517 | $54.14M | 9.75% | 00.0% | Unchanged |
| Q3 2025 | 1,784,517 | $53M | 10.52% | −713,534−28.6% | Reduced |
| Q2 2025 | 2,498,051 | $28.55M | 8.55% | 00.0% | Unchanged |
| Q1 2025 | 2,498,051 | $25.06M | 7.33% | 00.0% | Unchanged |
| Q4 2024 | 2,498,051 | $44.32M | 11.48% | 00.0% | Unchanged |
| Q3 2024 | 2,498,051 | $51.16M | 11.97% | 00.0% | Unchanged |
| Q2 2024 | 2,498,051 | $58.1M | 14.50% | +2,498,051 | New |